Numerous clinical trials are underway testing PD1/PDL1 inhibitors concurrent with chemoradiotherapy for oesophageal cancer, largely in the neoadjuvant setting [reviewed in Farinha et al. [12]]. This evidence concerns the gene CD274 and carcinoma of esophagus.